CINC Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: 15.60%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

CinCor Pharma Insider Trading History Chart

CinCor Pharma Share Price & Price History

^$29.06

▼ -0.14 (-0.48%)

As of 02/24/2023 09:00 PM ET

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

From Paradigm Press | Ad

You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.

Click here to find out that this 8,788% cryptocurrency is.

CinCor Pharma Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/15/2022	5Am Partners Vi, Llc	Major Shareholder	Buy	600,000	$30.00	$18,000,000.00	3,953,990
8/11/2022	James Healy	Director	Buy	506,000	$30.00	$15,180,000.00	6,073,949
8/11/2022	Sofinnova Venture Partners X,	Major Shareholder	Buy	500,000	$30.00	$15,000,000.00	6,073,949

The “Next Bitcoin”? 10 CENT Crypto Set to Explode

From True Market Insiders | Ad

The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…

Click For My #1 FREE Crypto for 2024

SEC Filings (Institutional Ownership Changes) for CinCor Pharma (NASDAQ:CINC)

99.15% of CinCor Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

CinCor Pharma Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/15/2023	Atom Investors LP	47,401	$0.58M	0.3%	N/A	0.108%
2/15/2023	venBio Partners LLC	383,390	$4.71M	1.5%	-79.4%	0.876%
2/14/2023	Driehaus Capital Management LLC	354,729	$4.36M	0.1%	-21.9%	0.811%
2/13/2023	Vivo Capital LLC	421,635	$5.18M	0.6%	+20.7%	0.964%
2/10/2023	Cheyne Capital Management UK LLP	67,557	$0.83M	1.5%	N/A	0.154%
2/9/2023	Landscape Capital Management L.L.C.	10,836	$0.13M	0.0%	N/A	0.025%
2/8/2023	Cambridge Investment Research Advisors Inc.	12,225	$0.15M	0.0%	+96.4%	0.028%
2/8/2023	Russell Investments Group Ltd.	40,062	$0.49M	0.0%	N/A	0.092%
2/7/2023	AlphaCentric Advisors LLC	70,000	$0.86M	0.8%	N/A	0.160%
2/2/2023	SG Americas Securities LLC	10,015	$0.12M	0.0%	N/A	0.023%
1/30/2023	New York State Common Retirement Fund	15,473	$0.19M	0.0%	+26.6%	0.035%
11/16/2022	Sandia Investment Management LP	5,000	$0.16M	0.0%	N/A	0.011%
11/15/2022	Perceptive Advisors LLC	3,306,649	$108.52M	3.1%	+42.6%	7.556%
11/15/2022	Ensign Peak Advisors Inc	78,480	$2.58M	0.0%	N/A	0.179%
11/15/2022	BVF Inc. IL	1,312,443	$43.07M	1.8%	-20.2%	2.999%
11/14/2022	Seven Grand Managers LLC	20,000	$0.66M	2.1%	N/A	0.046%
11/14/2022	Tudor Investment Corp Et Al	21,805	$0.72M	0.0%	N/A	0.050%
11/14/2022	Vivo Capital LLC	349,237	$11.46M	1.3%	N/A	0.798%
11/14/2022	Boothbay Fund Management LLC	13,718	$0.45M	0.0%	N/A	0.031%
11/14/2022	Integral Health Asset Management LLC	50,000	$1.64M	0.3%	+19.8%	0.114%
11/14/2022	MetLife Investment Management LLC	11,457	$0.38M	0.0%	+41.6%	0.026%
11/9/2022	Amalgamated Bank	2,670	$88K	0.0%	+27.0%	0.006%
11/8/2022	Sofinnova Investments Inc.	6,079,949	$199.54M	11.6%	+9.1%	13.894%
11/8/2022	State Board of Administration of Florida Retirement System	7,000	$0.23M	0.0%	N/A	0.016%
11/8/2022	New York State Common Retirement Fund	12,219	$0.40M	0.0%	+27.6%	0.028%
11/7/2022	TD Asset Management Inc.	49,730	$1.49M	0.0%	-4.3%	0.132%
11/3/2022	Barclays PLC	2,708	$89K	0.0%	+303.0%	0.007%
11/1/2022	Monashee Investment Management LLC	30,000	$0.99M	0.4%	N/A	0.079%
10/26/2022	Belvedere Trading LLC	27,218	$0.89M	0.0%	N/A	0.072%
10/17/2022	Bartlett & Co. LLC	800	$26K	0.0%	N/A	0.002%
10/17/2022	Cambridge Investment Research Advisors Inc.	6,225	$0.20M	0.0%	N/A	0.016%
8/16/2022	venBio Partners LLC	2,145,035	$40.41M	11.5%	+8.3%	5.684%
8/16/2022	Driehaus Capital Management LLC	487,279	$9.18M	0.1%	N/A	1.291%
8/11/2022	Artal Group S.A.	137,010	$2.58M	0.1%	N/A	0.363%
8/9/2022	Swiss National Bank	31,100	$0.59M	0.0%	N/A	0.082%
8/8/2022	Walleye Capital LLC	29,323	$0.55M	0.0%	+3.8%	0.078%
8/3/2022	Integral Health Asset Management LLC	41,748	$0.79M	0.2%	N/A	0.111%
6/30/2022	Amalgamated Bank	2,271	$40K	0.0%	N/A	0.006%
5/27/2022	Walleye Capital LLC	28,250	$0.50M	0.0%	N/A	0.075%
5/17/2022	RTW Investments LP	1,389,705	$24.38M	0.5%	N/A	3.685%
5/17/2022	Rock Springs Capital Management LP	1,031,159	$18.09M	0.5%	N/A	2.734%
5/17/2022	Great Point Partners LLC	79,670	$1.40M	0.3%	N/A	0.211%
5/16/2022	venBio Partners LLC	1,980,706	$34.74M	7.7%	N/A	5.252%
5/13/2022	Omega Fund Management LLC	966,176	$16.95M	3.5%	N/A	2.562%
5/13/2022	Sands Capital Ventures LLC	950,000	$16.66M	3.5%	N/A	2.519%
5/10/2022	TD Asset Management Inc.	51,965	$0.91M	0.0%	N/A	0.138%
5/5/2022	New York State Common Retirement Fund	9,500	$0.17M	0.0%	N/A	0.025%

Data available starting January 2016

CinCor Pharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment for cardio-renal diseases. It is involved in developing CIN-107, which is in Phase II clinical trial for the treatment of hypertension, primary aldosteronism, and other cardio-renal diseases, as well as in Phase I clinical trial to treat chronic kidney diseases. The company was incorporated in 2018 and is based in Waltham, Massachusetts.

Today's Range

Now: $29.06

$29.02

$29.35

50 Day Range

MA: $29.08

$28.73

$29.56

52 Week Range

Now: $29.06

$10.53

$43.15

Volume

6,349,700 shs

Average Volume

818,447 shs

Market Capitalization

$1.27 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of CinCor Pharma?: CinCor Pharma's top insider shareholders include:
James Healy (Director)
Sofinnova Venture Partners X, (Major Shareholder)
5Am Partners Vi, Llc (Major Shareholder)
Learn More about top insider investors at CinCor Pharma.